PPP2R2A and neoplasm: In addition, PPP2R2A has been proven to be a tumor inhibitor involved in the proliferation, invasion, and epithelial-to-mesenchymal transition (EMT) of cancer cells, including gastric cancer [12], liver cancer [13], and ovarian cancer [14].